Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biogazelle Develops Lab Products Beyond Industry Standards

Published: Wednesday, October 17, 2012
Last Updated: Wednesday, October 17, 2012
Bookmark and Share
New product line consists of 20000 individual real-time PCR assays.

Bio-Rad Laboratories has recently launched a new product line that was designed in conjunction with the Belgian company Biogazelle.

The new product line consists of 20000 individual real-time PCR assays, known as PrimePCR assays, all of which have been validated beyond international lab standards by Biogazelle.

The PrimePCR assays promise to save researchers time and resources to execute laboratory experiments in which the activity of particular human genes is measured.

Their use constitutes an important step to comply with recently established standards improving the quality and reliability of such experiments.

All PrimePCR assays were validated to comply with the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines.

A multidisciplinary team of bio-informaticians, lab technicians and academic experts have been working on this prestigious project for more than a year. “We are delighted that our development pipeline leads to the expansion of Bio-Rad’s portfolio, which underscores the commercial viability and success of our RD strategy focusing on quantitative PCR (qPCR) and its applications,” said Jo Vandesompele, Chief Executive Officer at Biogazelle.

qPCR is a widely used laboratory method for molecular nucleic acids research and diagnostics.

Being an acknowledged global leader in the qPCR field, Biogazelle is proud to be a developer and provider of products validated beyond industry standards and common research practice.

“Biogazelle provides researchers knowledge, products, services and analysis tools to support the quality and reliability of their qPCR analyses,” said Jan Hellemans, co-founder and Chief Executive Officer at Biogazelle.

Biogazelle is committed to contribute to scientific progress, accelerating discoveries when it comes to understand diseases, discover new biomarkers, support crop improvement or other developments that make our society a better place to live in.

Biogazelle will continue its long-term collaboration with Bio-Rad for the development of similar products in the years to come. Biogazelle’s development pipeline is working at full speed.

In 2013, the human PrimePCR assays will be complemented with qPCR assays for mouse, covering nearly all protein coding genes in human and mice.

Assays targeting protein-coding genes for other genomes and assays targeting other types of genes will follow shortly.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biogazelle Attracts New Investors
UGent spin-off Biogazelle attracts new investors QBIC Arkiv Fund, Foundation Majoie and SOFI to finance growth.
Tuesday, October 07, 2014
Biogazelle Serves as Reference Laboratory for Bio-Rad's ddPCR System
Biogazelle’s and Bio-Rad’s long-term partnership extends.
Monday, September 30, 2013
VIB Inks qBase+ Group Licensing Agreement with Biogazelle
VIB to accelerate its qPCR analyses by using qbase+ as the software.
Monday, May 20, 2013
Biogazelle Appoints Kris Vanhercke as Chief Operating Officer
New appointment strengthens business development and marketing expertise of Biogazelle.
Monday, September 24, 2012
Scientific News
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Gene Analysis System Could Accelerate Pace of Research on the Space Station
The WetLab-2 system will enable spaceflight genomic studies involving a wide variety of biospecimen types in the unique microgravity environment of space.
Liquid Biopsy for NSCLC
'Liquid biopsy' blood test accurately detects key genetic mutations in most common form of lung cancer, study finds.
Rare DNA Will Have Nowhere To Hide
Two National Institutes of Health grants back Rice University effort to develop new diagnostics.
Seeing Cell to Cell Differences
Seeing differences between individual cells for first time explains symptoms of rare genetic disorders, finds penn study.
Circular RNAs Implicated in Cancer
Circular RNAs – like their protein counterparts – are also affected by genomic rearrangements in cancer, resulting in abnormal fusions.
Know Thy Helicobacter pylori
Non-invasive method for genotyping H.pylori developed.
Zika Test Authorized for Emergency Use
n response to a request from the CDC, the FDA has issued an Emergency Use Authorization (EUA) for a diagnostic tool for Zika virus that will be distributed to qualified laboratories.
Lighting Up Disease-Carrying Mosquitoes
Sandia’s QUASR enables speedy, accurate detection of West Nile and other viruses.
Ultra-Sensitive Test for Cancers, HIV
Test developed that is thousands of times more sensitive than current diagnostics.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!